Title |
Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial
|
---|---|
Published in |
BMC Public Health, June 2012
|
DOI | 10.1186/1471-2458-12-488 |
Pubmed ID | |
Authors |
Perrine Roux, Laurent Michel, Julien Cohen, Marion Mora, Alain Morel, Jean-Francois Aubertin, Jean-Claude Desenclos, Bruno Spire, Patrizia M Carrieri, and the ANRS Methaville Study Group |
Abstract |
In France, the rapid scale-up of buprenorphine, an opioid maintenance treatment (OMT), in primary care for drug users has led to an impressive reduction in HIV prevalence among injecting drug users (IDU) but has had no major effect on Hepatitis C incidence. To date, patients willing to start methadone can only do so in a methadone clinic (a medical centre for drug and alcohol dependence (CSAPA) or a hospital setting) and are referred to primary care physicians after dose stabilization. This study aims to assess the effectiveness of methadone in patients who initiated treatment in primary care compared with those who initiated it in a CSAPA, by measuring abstinence from street opioid use after one year of treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 85 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 16 | 19% |
Student > Master | 12 | 14% |
Researcher | 10 | 12% |
Other | 8 | 9% |
Student > Doctoral Student | 3 | 4% |
Other | 13 | 15% |
Unknown | 23 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 35% |
Psychology | 7 | 8% |
Biochemistry, Genetics and Molecular Biology | 5 | 6% |
Social Sciences | 5 | 6% |
Nursing and Health Professions | 2 | 2% |
Other | 13 | 15% |
Unknown | 23 | 27% |